How much does RPH Pharma Ltd make?

RPH Pharma Ltd reported revenue of £13.5m and £720k profit in the year to 31 Dec 2024, according to its accounts filed at Companies House.

How many employees does RPH Pharma Ltd have?

RPH Pharma Ltd reported an average of 5 employees in the year to 31 Dec 2024.

Is RPH Pharma Ltd profitable?

Yes — RPH Pharma Ltd reported a profit of £720k in the year to 31 Dec 2024.

Company No. 11330646 · Incorporated 26 Apr 2018

RPH Pharma Ltd

Registered name: RPH PHARMA LTD

Part of Eqt Ab (Publ) group

RPH Pharma Ltd made £13.5m revenue and £720k profit in the year to 31 Dec 2024.

RPH Pharma Ltd’s revenue grew 371% to £13.5m in the year to 31 Dec 2024, with £720k profit and 5 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Cheadle Royal Business Park; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Cheadle Royal Business Park, North West
Age: 8 yrs · since 2018
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Small team

Revenue

£13.5m

Growth ▲371.1%

Profit

£720k

Growth ▲57.6%

Profit margin

5.3%

Gross 18.7%

Employees

Change —

Profit / employee

£144k

Revenue/employee £2.7m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	31 Dec 2022	31 Dec 2023	31 Dec 2024
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£989k	£1.9m	£2.9m	£13.5m
Cost of sales	£374k	£1.1m	£2.2m	£11m
Gross profit	£615k	£822k	£719k	£2.5m
Operating profit	£343k	£605k	£528k	£1.8m
Profit before tax	£343k	£605k	£573k	£1m
Profit after tax	£278k	£471k	£457k	£720k
Profit (best available)	£278k	£471k	£457k	£720k
Staff costs	—	—	—	£541k
Employees (average)	—	0	0	5
Ratios
Profit margin	28.1%	24.4%	15.9%	5.3%
Gross margin	62.2%	42.6%	25%	18.7%
Revenue per employee	—	—	—	£2.7m
Profit per employee	—	—	—	£144k
Growth (year on year)
Revenue growth	—	▲95.2%	▲48.8%	▲371.1%
Profit growth	—	▲69.5%	▼3.1%	▲57.6%
Balance sheet — indirect signals, not revenue
Cash at bank	£329k	£971k	£481k	—
Net assets	£338k	£159k	£616k	£1.3m
Current assets	£503k	£1.1m	£1.4m	£11.1m
Debtors	£174k	£142k	£920k	£1.9m
Deferred income	£9.3k	£82.4k	£168k	£831k
Source	Accounts · bulk data Oct 2023	Accounts · bulk data Oct 2023	FullAccounts · bulk data Sep 2024	FullAccounts · bulk data Sep 2025

Derived from the latest filing

How the business works

Profit margin: 5.3%; Profit ÷ revenue.
Gross margin: 18.7%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £2.7m; Revenue ÷ average employees.
Profit per employee: £144k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 6.1%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 13.8%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲117%; Now £1.3m
Cash at bank: —; Now —
Headcount: —; Now 5
Deferred income: ▲395%; Now £831k
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Eqt Ab (Publ) (registered outside the UK register)ultimate parent75–100%
RPH Pharma Ltdthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit £720k), from the Companies House accounts bulk data published Sep 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.